Royce Global Trust Inc. Common Stock (RGT)
FairStock Score: 44/100 — MIXED
Key Financials
| Current Price | $14.38 |
| Market Cap | $95M |
| P/E Ratio | 2.67 |
| ROE | —% |
| Dividend Yield | 1.32% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At $14.18 at the close on 2026-10-13, Royce Global Trust carries a market value of just $94.9 million and a FairStock-calculated P/E of 2.64 against the provided EPS input of $5.38. On the surface, that is the kind of quotation a Graham-style investor notices. The FairStock Graham Number is $42.95, implying a margin of safety of 66.98%, and the 1.34% dividend yield offers a small return while waiting. An Altman Z-Score of 132.05 might suggest enormous solvency, though for an asset manager such ratios can be distorted. The trouble is what I cannot see. There is no P/B, ROE, ROCE, D/E, revenue growth, or profit growth in the data, and only zero years of filed results for Lynch categorization. A Piotroski F-Score of 0/9 is a red flag: on the available calculation, financial health looks poor rather than improving. The FairStock Score of 44/100 reinforces that the apparent cheapness is not confirmed by quality. In asset management, the real moat is scale, brand, distribution, and sticky assets under management; the data do not let me judge any of that. The earnings figure may be recurring or may reflect one-time items, and without several years of filings I cannot tell. So I would treat this as a statistically cheap but unproven special situation: price is low relative to stated EPS and the Graham Number, but the absence of history and weak health score demand skepticism. Growth trajectory is simply unknown from the filed figures provided.
In plain English: Royce Global Trust is a U.S.-domiciled asset manager. Its shares trade at $14.18 after the close on 2026-10-13, and they look cheap compared with the company's stated earnings and a calculated value measure, but many financial details are missing. A weak financial-health score and no multi-year filing record make the business hard to judge, so the cheapness is not clearly dependable.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer